Overview

Update
IPO / Stock
Went Public on Sep 17, 2014 / NASDAQ:PRTO
Total Equity Funding
$145.54M in 6 Rounds from 12 Investors
Headquarters:
Waltham, MA
Description:
Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.
Founders:
,
Categories:
Pharmaceutical, Biotechnology, Medical
Website:
http://www.proteontherapeutics.com

Company Details

Update

Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.

The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.

Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures.

The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

Funding Rounds (6) - $145.54M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2014$45M / Series D9
Feb, 2014$4.34M / Venture0
Aug, 2011$15.2M / Series C0
May, 2009$50M / Series B8
Sep, 2007$12M / Series A6
Mar, 2006$19M / Series A4

Current Team (1)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Proteon Therapeutics

    200 West Street

    Waltham, MA 02451

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos